Abstract Number: 2600 • 2012 ACR/ARHP Annual Meeting
Assessment of Quality of Care for Incident Lupus Nephritis in the U.S. Medicaid Population
Background/Purpose: The contribution of uneven health care quality to racial/ethnic and socioeconomic disparities in lupus nephritis outcomes is unknown. We aimed to assess performance on…Abstract Number: 2601 • 2012 ACR/ARHP Annual Meeting
Improving Delivery of Care for JIA Across a Multi-Center Network Using a Shared Data Registry and Quality Improvement Science: The Pediatric Rheumatology Care and Outcomes Improvement Network
Background/Purpose: The Pediatric Rheumatology Care and Outcomes Improvement Network (PR-COIN) is a quality improvement (QI) multi-center “learning network” that performs QI and research while tracking…Abstract Number: 2602 • 2012 ACR/ARHP Annual Meeting
The Rheumatology Informatics System for Effectiveness (RISE): Enabling Data Access Across Disparate Sites for Quality Improvement and Research
Background/Purpose: Rheumatology quality improvement efforts and clinical research are often challenged by the need to access and integrate data across diverse patient populations and disparate information…Abstract Number: 2603 • 2012 ACR/ARHP Annual Meeting
Moving Into the Electronic Age: Validation of Rheumatology Self-Assessment Questionnaires On Tablet Computers
Background/Purpose: The medical field is increasingly relying on electronic health records (EHR). Many children’s hospitals are converting from paper-pencil questionnaires to electronic versions. The purpose…Abstract Number: 2604 • 2012 ACR/ARHP Annual Meeting
Ask a Doc – Rheumatologic Care Delivered Just in Time
Background/Purpose: Specialty care is traditionally delivered as face to face consults. These encounters range from consult not needed to consult needed quickly. Our care systems…Abstract Number: 2605 • 2012 ACR/ARHP Annual Meeting
Exploration of Possible Preliminary Descriptions of Remission Based On RAPID3, without Laboratory Tests or Formal Joints Counts but with Careful Joint Examinations, in the Etude Et Suivi Des Polyarthrites Indifférenciées Récentes (ESPOIR) Cohort of Early Rheumatoid Arthritis Patients
Background/Purpose: Criteria for remission in rheumatoid arthritis (RA) have been developed according to DAS28 (disease activity score), CDAI (clinical disease activity index), and two recent…Abstract Number: 2566 • 2012 ACR/ARHP Annual Meeting
Aβ-Related Angiitis: Comparison with Patients with Amyloid Cerebral Angiopathy without Inflammation
Background/Purpose: Coexistence of sporadic cerebral amyloid angiopathy (CAA) and primary central nervous system vasculitis (PCNSV) has been reported, particularly in patients with granulomatous vasculitis. This…Abstract Number: 2567 • 2012 ACR/ARHP Annual Meeting
Predictive Value of Selected Markers of Inflammation and Platelet Activation for Complete Remission in ANCA – Associated Vasculitis
Background/Purpose: Most subjects with ANCA –associated vasculitis (AAV) respond to treatment for remission induction, but predictors for complete disease remission are lacking. We have previously…Abstract Number: 2568 • 2012 ACR/ARHP Annual Meeting
The Risk of Pulmonary Embolism and Deep Vein Thrombosis in Giant Cell Arteritis: A Population-Based Cohort Study
Background/Purpose: A recent hospital-based study has suggested an 8 fold increased risk of pulmonary embolism (PE) in individuals with polymyalgia rheumatica in the year following…Abstract Number: 2569 • 2012 ACR/ARHP Annual Meeting
Hydroxychloroquine Reduces Thrombosis in Systemic Lupus Erythematosus, Particularly in Antiphospholipid Positive Patients
Background/Purpose: Past studies, mostly cross-sectional, have found a reduction in thrombosis in systemic lupus erythematosus (SLE) patients taking hydroxychloroquine (HCQ). We examined the relationship between…Abstract Number: 2570 • 2012 ACR/ARHP Annual Meeting
Lymphoma Risk in Systemic Lupus: Effects of Disease Activity Versus Treatment
Background/Purpose: In systemic lupus (SLE), concern exists about immunosuppressive drugs and lymphoma risk, Yet, the relative influence of disease activity vs treatment, is unknown. Our objective…Abstract Number: 2571 • 2012 ACR/ARHP Annual Meeting
Lack of Control of Hypertension in Systemic Lupus Erythematosus
Background/Purpose: Hypertension is an independent risk factor for both actual cardiovascular events and also subclinical atherosclerosis (coronary calcium, carotid IMT) in SLE. We examined the…Abstract Number: 2572 • 2012 ACR/ARHP Annual Meeting
Molecular Signatures in SLE: Flare Vs. Infection
Background/Purpose: Inability to distinguish between infection and the inflammatory response related to SLE disease activity using clinical judgment often compromises timely and effective treatment. Gene…Abstract Number: 2573 • 2012 ACR/ARHP Annual Meeting
Arthoplasty Rates Increased Among US Patients with Systemic Lupus Erythematosus: 1991-2005
Background/Purpose: There is little data regarding patterns of arthroplasty use in patients with Systemic Lupus Erythematosus (SLE). This study evaluates trends in total joint replacement…Abstract Number: 2574 • 2012 ACR/ARHP Annual Meeting
Smoking, Autoantibodies and Vascular Events in Systemic Lupus Erythematosus
Background/Purpose: Smoking is a risk factor for several autoimmune diseases including rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Smoking is also a major risk…